300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Email
Photography
Payments
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Blockchain
Facebook
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
LGBT
Celebrity
Climate
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Iran
Isle of Man
Guinea
Nepal
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Sudan
Andorra
Colombia
Armenia
China
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Botswana
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
University of Glasgow, VC Fund

University of Glasgow

VC Fund

Glasgow, United Kingdom

University of Glasgow is a VC fund in Glasgow focused on Biotechnology and Sensor. Founded in 1451, the University of Glasgow is the fourth oldest university in the English-speaking world. Today we are in the top 1% of the world's universities.Glasgow’s college system enables interdisciplinary collaboration while fostering a sense of belonging. We have four colleges, each bringing together the research and teachingexpertise of a number of schools and institutes. Every college also has a graduate school.The University is expanding and evolving. Following the closure of the Western Infirmary site in 2015, we plan to invest £80m in new buildings and equipment and £55m on refurbishing facilities over the next five years.

Total investments:
5
Last investment:
Lead investor:
20%

Last updated:

Industries University of Glasgow invests in

BiotechnologySensorHealth CareNanotechnologyPharmaceutical

Stages University of Glasgow invests in

Pre-SeedSeries ASeed

Countries University of Glasgow invests in

United Kingdom

Contacts

NameEmailPhoneSocials
Chris Pearce Chris Pearce
Esther K. Papies Esther K. Papies
Mahmood Adil Mahmood Adil
Paul Siebert Paul Siebert
Phil Trinder Phil Trinder

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Biotechnology 2 (40%)
  • Sensor 1 (20%)
  • Health Care 1 (20%)
  • Nanotechnology 1 (20%)
  • Pharmaceutical 1 (20%)

Stage

  • Pre-Seed 2 (40%)
  • Series A 2 (40%)
  • Seed 1 (20%)

Team

NameTitleInvestmentsLinksEmail
Chris Pearce
Chris Pearce Professor of Computational Mechanics & Vice Principal (Research)
Professor of Computational Mechanics & Vice Principal (Research) Total investments: 0
Find email
Esther K. Papies
Esther K. Papies Researcher in Behaviour Change
Researcher in Behaviour Change Total investments: 0
Find email
Mahmood Adil
Mahmood Adil Honorary Professor of Health Intelligence and Service Effectiveness
Honorary Professor of Health Intelligence and Service Effectiveness Total investments: 0
Find email
Paul Siebert
Paul Siebert Reader
Reader Total investments: 0
Find email
Phil Trinder
Phil Trinder Professor
Professor Total investments: 0
Find email
See all 11 team members →

Investments

CompanyDescriptionRoundLinks
Neuranics Neuranics
Neuranics is a company that creates magnetic sensors that are integrated with semiconductor technology for use in health, fitness, and metaverse applications. Neuranics' proprietary technology detects tiny magnetic impulses from organs of the body using scalable spintronics sensors powered by semiconductors. According to the business, thetechnology could solve the current inadequacies of health monitoring equipment and human-machine interfaces. $8M / Seed / Apr 09, 2025
Solasta Bio Solasta Bio
Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection. $14M / Series A / Sep 11, 2024
Clyde Hydrogen Systems Clyde Hydrogen Systems
Clyde Hydrogen methods is a technological business that is developing breakthrough methods for large-scale green hydrogen production. $1.3M / Pre-Seed / Apr 10, 2024
Neuranics Neuranics
Neuranics is a company that creates magnetic sensors that are integrated with semiconductor technology for use in health, fitness, and metaverse applications. Neuranics' proprietary technology detects tiny magnetic impulses from organs of the body using scalable spintronics sensors powered by semiconductors. According to the business, thetechnology could solve the current inadequacies of health monitoring equipment and human-machine interfaces. $2.5M / Pre-Seed / Sep 27, 2023
Clyde Biosciences Clyde Biosciences
Clyde Biosciences – experts in the field of developmental drug testing, giving unique insights into the working mechanisms and actions of drugs under development. $2.6M / Series A / Apr 13, 2015

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Email
Photography
Payments
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Blockchain
Facebook
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
LGBT
Celebrity
Climate
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Iran
Isle of Man
Guinea
Nepal
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Sudan
Andorra
Colombia
Armenia
China
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Botswana
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does University of Glasgow invest in?

University of Glasgow invests primarily in Biotechnology, Sensor and Health Care startups, most often at Pre-Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact University of Glasgow?

Public channels for University of Glasgow include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at University of Glasgow?

The team at University of Glasgow includes Chris Pearce (Professor of Computational Mechanics & Vice Principal (Research)), Esther K. Papies (Researcher in Behaviour Change) and Mahmood Adil (Honorary Professor of Health Intelligence and Service Effectiveness), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
University of Glasgow University of Glasgow Find emails